Repaglinide, but Not Nateglinide Administered Supraspinally and Spinally Exerts an Anti-Diabetic Action in D-Glucose Fed and Streptozotocin-Treated Mouse Models

@inproceedings{Sim2013RepaglinideBN,
  title={Repaglinide, but Not Nateglinide Administered Supraspinally and Spinally Exerts an Anti-Diabetic Action in D-Glucose Fed and Streptozotocin-Treated Mouse Models},
  author={Y Y Sim and Soo-Hyun Park and Yu-Jung Kang and Sung-Su Kim and Chea-Ha Kim and Su-Jin Kim and Su-Min Lim and J Jung and Ohk-Hyun Ryu and Moon-Gi Choi and H W Suh},
  booktitle={The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology},
  year={2013}
}
We have recently demonstrated that some anti-diabetic drugs such as biguanide and thizolidinediones administered centrally modulate the blood glucose level, suggesting that orally administered anti-diabetic drugs may modulate the blood glucose level by acting on central nervous system. The present study was designed to explore the possible action of another class of anti-diabetic drugs, glinidies, administered centrally on the blood glucose level in ICR mice. Mice were administered… CONTINUE READING